ABSTRACT
Preceded by a brief commentary about the clinical characteristics of actinic prurigo, the qualities of anantifibrinolytic medication and its possible machanism of action in allergic conditions and atopias are analysed. An earlier experience with five familiar cases of actinic prurigo given 1 g of tranexamic acid or 3 g E. ACA, within a period of three months has been effective remarkally exceeding the results obtained with other therapeutic agents. The proposed therapeutic scheme may or may not be, modified, according to the response to the response of each individual case.
Subject(s)
Antifibrinolytic Agents/therapeutic use , Facial Dermatoses/etiology , Prurigo/drug therapy , Sunlight , Adolescent , Adult , Aminocaproic Acid/therapeutic use , Dermatitis, Atopic/drug therapy , Dermatitis, Atopic/genetics , Drug Evaluation , Drug Therapy, Combination , Facial Dermatoses/drug therapy , Facial Dermatoses/genetics , Female , Humans , Male , Prurigo/etiology , Prurigo/genetics , Tranexamic Acid/therapeutic useABSTRACT
A patient with palatal hemangioma was subjected to study and the general characteristics of buccal hemangioma are analyzed. Their infrequent occurrence being remarkable. Maxillar angiomas have a reserved prognosis not only because of their histologic malignancy but also because of the threat of incoercible hemorrhage with the removal of dentures. Therefore radical surgical intervention or eventual radiotherapy is indicated.
